We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
-13.26%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
10 Year Est. Return
AUM
$34.1M
AUM Growth
-$23.3M
Cap. Flow
-$16M
Cap. Flow %
-46.8%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
3
Closed

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLT
1
DELISTED
CATALENT, INC.
CTLT
$11.8M 34.49%
109,684
-66,609
-38% -$6.78M
AZTA icon
2
Azenta
AZTA
$1.23B
$11.8M 34.48%
163,176
-104,820
-39% -$7.83M
CRL icon
3
Charles River Laboratories
CRL
$11B
$10.6M 31.02%
49,470
-5,530
-10% -$1.35M

Similar funds

Tower House Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Tower House Partners held 3 positions worth $34.1M, down 41% from $57.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $16M in Q2 2022, reducing 3 holdings. Its largest reduction was Azenta, cutting an estimated $7.83M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tower House Partners's biggest Q2 2022 reduction was Azenta, cutting an estimated $7.83M.
  • Tower House Partners's ten largest holdings make up 100% of its $34.1M portfolio in Q2 2022.
  • Tower House Partners opened 0 new positions and closed 0 in Q2 2022.
  • Tower House Partners's portfolio value fell 41% quarter-over-quarter to $34.1M.

Based on Tower House Partners's 13F filing for Q2 2022, filed 15 Aug 2022.